The big picture about Lumosity, Posit Science and Emotiv

You can now enjoy the slide deck from this ses­sion, which took place at the 2013 Sharp­Brains Vir­tu­al Sum­mit (Sep­tem­ber 19–20th).

How can inno­va­tors lever­age crowd­fund­ing and strate­gic invest­ments to gain dis­tri­b­u­tion reach?  With dis­tri­b­u­tion as a com­mon bot­tle­neck to the sus­tain­able com­mer­cial­iza­tion of inno­va­tion, val­ue-added cap­i­tal is often crit­i­cal to enable steady progress in the trans­la­tion of brain sci­ence from lab to life. This is espe­cially true in non-med­ical areas, which lack appro­pri­ate infra­struc­ture to com­mer­cial­ize and dis­trib­ute inno­v­a­tive solu­tions. What can inno­va­tors learn from Discovery’s invest­ment in Lumos­ity, AAA’s part­ner­ship with Posit Sci­ence, and Emotiv’s Kick­starter crowd­fund­ing campaign?

• Chair: Matthew Bish­op, US Busi­ness Edi­tor and New York Bureau Chief of The Economist
• Dan Fox, Senior VP Cor­po­rate Devel­op­ment at Dis­cov­ery Communications
• Jeff Zim­man, Chair­man of Posit Science
• Tan Le, CEO of Emo­tiv Lifesciences